Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C T Cramer

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Chemico-Biological Interactions|May 5, 2001
Metabolic, idiosyncratic toxicity of drugs: overview of the hepatic toxicity induced by the anxiolytic, panadiplonR G Ulrich, J A Bacon, E P Brass, et al.
Toxicology|January 9, 1999
Disruption of mitochondrial activities in rabbit and human hepatocytes by a quinoxalinone anxiolytic and its carboxylic acid metaboliteR G Ulrich, J A Bacon, C T Cramer, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|January 1, 1990
Hepatic changes produced by 30-day administration of a novel aminocyclitol antibiotic, trospectomycin sulfate, to laboratory animalsR G Ulrich, D K Petrella, E R Larsen, et al.
Toxicology Letters|December 1, 1995
Cultured hepatocytes as investigational models for hepatic toxicity: practical applications in drug discovery and developmentR G Ulrich, J A Bacon, C T Cramer, et al.
Toxicology|April 12, 1995
Induction of a hepatic toxic syndrome in the Dutch-belted rabbit by a quinoxalinone anxiolyticR G Ulrich, J A Bacon, D G Branstetter, et al.
Die Pharmazie|March 11, 2006
Long hydrocarbon chain diols and diacids with central ether or ketone moieties that favorably alter lipid disordersD C Oniciu, E Pop, J L H Dasseux, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Chemico-Biological Interactions|May 5, 2001
Metabolic, idiosyncratic toxicity of drugs: overview of the hepatic toxicity induced by the anxiolytic, panadiplonR G Ulrich, J A Bacon, E P Brass, et al.
Toxicology|January 9, 1999
Disruption of mitochondrial activities in rabbit and human hepatocytes by a quinoxalinone anxiolytic and its carboxylic acid metaboliteR G Ulrich, J A Bacon, C T Cramer, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|January 1, 1990
Hepatic changes produced by 30-day administration of a novel aminocyclitol antibiotic, trospectomycin sulfate, to laboratory animalsR G Ulrich, D K Petrella, E R Larsen, et al.
Toxicology Letters|December 1, 1995
Cultured hepatocytes as investigational models for hepatic toxicity: practical applications in drug discovery and developmentR G Ulrich, J A Bacon, C T Cramer, et al.
Toxicology|April 12, 1995
Induction of a hepatic toxic syndrome in the Dutch-belted rabbit by a quinoxalinone anxiolyticR G Ulrich, J A Bacon, D G Branstetter, et al.
Die Pharmazie|March 11, 2006
Long hydrocarbon chain diols and diacids with central ether or ketone moieties that favorably alter lipid disordersD C Oniciu, E Pop, J L H Dasseux, et al.
Pageof 2